World J Gastroenterol. 2012 May 28; 18(20): 2561-2568.
Published online 2012 May 28. doi: 10.3748/wjg.v18.i20.2561.
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
Prevalence of depressive and anxiety disorders in Chinese gastroenterological outpatients
Xiao-Jing Li, Ling Zhang, Lan Zhang, Mental Health Center of West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Yan-Ling He, Shanghai Mental Health Center, Shanghai Jiao Tong University, Shanghai 200030, China
Hong Ma, Peking University Institute of Mental Health, Beijing 100007, China
Zhe-Ning Liu, Mental Health Institute of the Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China
Fu-Jun Jia, Guangdong Mental Health Center, Guangdong General Hospital, Guangzhou 510120, Guangdong Province, China
Received November 10, 2011; Revised February 20, 2012; Accepted March 9, 2012;
AIM: To investigate the prevalence and physicians’ detection rate of depressive and anxiety disorders in gastrointestinal (GI) outpatients across China.
METHODS: A hospital-based cross-sectional survey was conducted in the GI outpatient departments of 13 general hospitals. A total of 1995 GI outpatients were recruited and screened with the Hospital Anxiety and Depression Scale (HADS). The physicians of the GI departments performed routine clinical diagnosis and management without knowing the HADS score results. Subjects with HADS scores ≥ 8 were subsequently interviewed by psychiatrists using the Mini International Neuropsychiatric Interview (MINI) to make further diagnoses.
RESULTS: There were 1059 patients with HADS score ≥ 8 and 674 (63.64%) of them undertook the MINI interview by psychiatrists. Based on the criteria of Diagnostic and Statistical Manual of Mental Disorders (4th edition), the adjusted current prevalence for depressive disorders, anxiety disorders, and comorbidity of both disorders in the GI outpatients was 14.39%, 9.42% and 4.66%, respectively. Prevalence of depressive disorders with suicidal problems [suicide attempt or suicide-related ideation prior or current; module C (suicide) of MINI score ≥ 1] was 5.84% in women and 1.64% in men. The GI physicians’ detection rate of depressive and anxiety disorders accounted for 4.14%.
CONCLUSION: While the prevalence of depressive and anxiety disorders is high in Chinese GI outpatients, the detection rate of depressive and anxiety disorders by physicians is low.
Keywords: Depression, Anxiety, Prevalence, Gastrointestinal outpatients, Mini International Neuropsychiatric Interview
Gastrointestinal (GI) disease is a serious illness, which frequently affects a patient’s physical and emotional wellbeing as well as being heavily affected by stress[1-3
]. Meanwhile depression and anxiety have been identified as risk factors for some GI diseases[4-6
Various studies using a variety of assessment methods have demonstrated that high levels of depression and anxiety exist in patients with GI symptoms[7-9
]. It has also been shown that patients with comorbid anxiety and depressive disorders tend towards more severe symptoms, longer recovery times, poorer outcomes, and greater use of healthcare resources[10-12
]. Despite the likelihood of GI patients to suffer from emotional distress, it has been reported that physicians in the GI department often fail to identify most cases of depression and/or anxiety, leading to under-treatment in 40%-90% of patients[13-16
Patients with depressive and anxiety disorders often have one or more somatic symptoms (e.g., cardiopulmonary or gastrointestinal), which may be partly induced by emotional disorders[17-19
]. On the other hand, many patients with depression or anxiety visit non-psychiatric departments, especially the GI department, for their physical complaints[20-22
]. All these facts contribute to the low detection rate of emotional disorders among GI patients.
It is necessary to determine prevalence estimates of emotional disorders in GI patients to facilitate reasonable medical resources allocation. These have been assessed in a number of studies throughout America, Europe, and China, including the Hong Kong and Taiwan regions[15,23-25
]. However, the economic status and cultural traditions of mainland China are unique, and likely to make the situation of mainland Chinese GI patients distinctive.
This is the first large-sample, multicenter study based on a mainland Chinese population to estimate the prevalence of depression and anxiety in adult GI outpatients. This cross-sectional study was carried out with GI outpatients from 13 tertiary general hospitals in Beijing, Shanghai, Guangzhou, Changsha and Chengdu. The purpose of this study was to characterize the prevalence of depressive and/or anxiety disorders among GI outpatients and to determine the non-psychiatric physician identification rate of these disorders in GI outpatients.
MATERIALS AND METHODS
This survey was approved by the Shanghai Mental Health Center Ethics Committee. All patients provided informed written consent.
A multi-center, cross-sectional study was carried out in the outpatient departments of 15 tertiary general hospitals in Beijing, Shanghai, Guangzhou, Changsha, and Chengdu to estimate the prevalence of depressive and anxiety disorders in adult outpatients from gastroenterology, gynecology, cardiovascular and neurology departments. However, only 13 hospitals provided complete data for the GI department (one lacked a GI department, and the other incomplete patient data). Consecutive patients visiting outpatient departments were recruited for the study. Patients were included if they were over 18 years, consented to study participation, and were able to complete the questionnaires. Exclusion criteria included being previously screened, serious physical or mental condition, language or hearing problem, incomplete records, or ongoing psychological treatment. About 140 consecutive GI outpatients were investigated in each hospital during 4-5 consecutive working days randomly selected from the 22 normal workdays in a month by using SAS (v9.0) software.
The somatic symptoms, as well as depression/anxiety, were assessed with the Patient Health Questionnaire 15-Item (PHQ-15)[26
], Hospital Anxiety and Depression Scale (HADS)[27,28
], and Mini International Neuropsychiatric Interview (MINI)[29
]. PHQ-15 is a self-report questionnaire used to screen and assess somatic symptoms. It consists of 15 physical symptoms, scaled 0-2 points for each. The higher the score, the more severe the symptom. The 14-item HADS[27,28
] questionnaire evaluates severity of anxiety and depression using 7 items for each affliction, and is widely used in general hospitals. Each item’s severity is rated from 0 (none) to 3 (severe). Scores ≥ 8 indicate probable anxiety or depression with great reliability and validity[30
], and were regarded as positive in the preliminary screening of this study. MINI[29
], a structured diagnostic instrument, is used to make diagnoses according to the Diagnostic and Statistical Manual of Mental Health Disorders (4th edition, DSM-IV) and the International Statistical Classification of Disease-10. The MINI Chinese version has good reliability and validity[31-33
This multi-center, cross-sectional study was carried out in five cities: Beijing, Shanghai, Guangzhou, Chengdu, and Changsha (representing north, east, south, west and central China, respectively). In the first stage, outpatients were screened with PHQ-15 and HADS scales, and then visited GI physicians for their original complaints. The coordinators calculated scores of both scales, kept physicians blind to results, and recorded physicians’ diagnosis and treatment. In the second stage, subjects with HADS scores ≥ 8 were assessed and diagnosed by psychiatrists with MINI. The study design is shown in Figure .
Flowchart of the study on prevalence of depressive disorders and/or anxiety disorders among gastrointestinal outpatients from 13 general hospitals in China. PHQ-15: Patient Health Questionnaire 15-Item; HADS: Hospital Anxiety and Depression Scale; MINI: Mini International Neuropsychiatric Interview.
Data analysis and management were performed using the Statistical Package for Social Sciences v17 (SPSS Inc., Chicago, IL, United States). Demographic data were described by frequency and percentage, and the lack of data in one item, such as sex or diagnosis, was treated as a missing value. Subjects who were positive in the preliminary screening stage but did not complete the psychiatrists’ interview were excluded.
According to a previous publication[34
], prevalence was described as the percentage of positive subjects among those who completed the trial, and adjusted prevalence was calculated according to the HADS score distribution among all eligible subjects. The 95% CI of adjusted prevalence were computed using the Gaussian approximation to the log-likelihood. Categorical data, such as differences of prevalence in sex and age, or differences between individuals with and without depressive and/or anxiety disorders, were compared using the χ2
test at the < 0.05 significance level. Consecutive data with normal distribution, such as age, were expressed as mean ± SD and analyzed using the t
“Recognized” or “detected” indicated diagnosis of depressive or anxiety disorders according to a physician’s clinical judgment, prescription of antidepressants or antianxiety drugs, or referral to psychiatry or psychology departments.
The study comprised 1995 outpatients, aged 18-89 (45.2 ± 15.6) years and 54.19% were female. The patients’ demographic characteristics are presented in the first two columns of Table . One thousand and fifty-nine subjects screened positive (HADS score ≥ 8), 580 (54.77%) of whom were female. Among these 1059, 674 completed the second stage screening of psychiatrists’ interview with MINI. Among the missing subjects (n = 385), 173 (44.9%) did not complete the further interview and 212 (55.1%) refused to attend the interview (Figure ). There were no significant differences between missed and followed-up cases in sex (χ2 = 0.066, P = 0.797) or age (43.72 ± 15.45 vs 42.89 ± 14.92, t = -0.860, P = 0.390).
Baseline characteristics and comparison of subjects with and without depressive disorders and/or anxiety disorders n (%)
Of the completed subjects, 371 (55.0%) were women and 323 (47.9%) were diagnosed with one or more types of depressive disorders and/or anxiety disorders. Among the 323 confirmed subjects, 194 (60.1%) were women (other characteristics are described in the third column of Table ). Subjects with depressive and/or anxiety disorders were more likely to be female and younger than those without such disorders (Table ).
Prevalence of depressive and anxiety disorders in gastrointestinal outpatients
The adjusted prevalence of depressive and anxiety disorders are shown in Table . One hundred and eighty-one subjects had current depression disorders, 117 had current anxiety disorders, and 59 had current comorbidity. This indicates that 32.6% (59/181) of individuals with current depressive disorders had at least one type of anxiety disorder, and 50.4% (59/117) of subjects with current anxiety disorders were affected by depressive disorders as well.
Adjusted prevalence of depressive and anxiety disorders among gastrointestinal outpatients in 13 general hospitals in mainland China and Diagnostic and Statistical Manual of Mental Health Disorders (4th edition) by using the Mini International Neuropsychiatric Interview
The prevalence of all types of depressive disorders and anxiety disorders, according to DSM-IV criteria, are detailed in Table . Among the depressive disorders, depressive episode was the most common with an adjusted current prevalence of 11.23%, while substance-induced mood disorder had the lowest adjusted current prevalence (0.35%). Among 181 outpatients with depressive disorders, 51 (28.2%) had suicidal problems [suicide attempt or suicide-related ideation prior or current; module C (suicide) of MINI, score ≥ 1], indicating that over a quarter of individuals with depressive disorders were at suicide risk.
Sex differences among current prevalence of depressive disorders and/or anxiety disorders
The current adjusted prevalence of depressive disorders and/or anxiety disorders was significantly different between male and female outpatients (Table ). The prevalence of depressive disorders, anxiety disorders, and either depressive or anxiety disorders was significantly (P < 0.05) higher in female GI outpatients. The adjusted current prevalence of depressive disorders with suicidal problems was statistically significantly higher in women (mean 5.84%; 95% CI: 4.44-7.24) than in men (mean 1.64%; 95% CI: 0.82-2.46) (χ2 = 23.096, P = 0.00), and the mean relative risk was 3.71 (95% CI: 2.10-6.56, P < 0.01).
Current adjusted prevalence of depressive disorders and/or anxiety disorders and comparison between men and women
Physicians’ detection and treatment of depressive and anxiety disorders in gastrointestinal outpatients
Among 323 digestive outpatients who were diagnosed with depressive disorders and/or anxiety disorders by MINI, complete information of physicians’ diagnoses and treatments was available for 290 cases (n = 13 missing diagnosis information, and n = 21 missing treatment information).
The detection rate by physicians was 4.14% (12/290). Among the 12 detected subjects, five were treated with psychotropic drugs, including amitriptyline or doxepin (n = 2). Another seven were referred to the psychiatry department. Meanwhile, three out of 67 (4.48%) subjects with suicide risk were identified and received psychiatric management, including psychiatry department referral (n = 1) and doxepin treatment (n = 2).
The current study evaluated the prevalence of depressive and anxiety disorders among mainland Chinese outpatients visiting GI clinics, regardless of confirmed GI diagnosis. The adjusted current prevalence of depressive disorders, anxiety disorders, and comorbid disorders was 14.39%, 9.42% and 4.66%, respectively.
It is well recognized that depressive and anxiety disorders impair life quality and cause a heavy disease burden[35-38
]. Nevertheless, more than half of patients with depression or anxiety visit non-psychiatric departments, especially the GI department, for somatic symptoms[20,21,39,40
]. However, most general physicians are not appropriately trained in psychiatry and cannot diagnose or treat depressive and anxiety disorders. Thus, GI physicians tend towards a low detection rate[41-43
]. It is meaningful to investigate overall prevalence of depressive and/or anxiety disorders in GI outpatients to understand the actual patient population involved and the importance of diagnosing such disorders.
According to our knowledge, this is the largest study investigating the prevalence of depressive and anxiety disorders in GI outpatients from tertiary general hospitals in mainland China. The reliability of the current prevalence figures was assured by the use of experienced psychiatrists administering a structured diagnostic instrument. The tertiary general hospitals enrolled in this study were distributed in north (Beijing), east (Shanghai), south (Guangzhou), west (Chengdu) and central (Changsha) China, and represent the majority of national tertiary general hospitals. In addition, the DSM-IV-based MINI was used by experienced psychiatrists to produce accurate and consistent diagnoses. Finally, the study was carried out in two stages, preliminary screening and diagnostic interview.
Prevalence of depressive disorders and/or anxiety disorders in general hospitals or primary care
The overall prevalence figures of depressive disorders and/or anxiety disorders in general medical care have been reported previously[15,44
]. The current adjusted prevalence of depressive disorders in our study was 14.39%. However, this value was 19.5% in a meta-analysis of primary care patients in ten countries[41
]. The current adjusted prevalence of anxiety disorders reported in our study was 9.42%, which was lower than the 19.0% prevalence reported among Belgian outpatients in 86 general practices[45
] and the 19.5% prevalence reported in 15 United States general medical care centers[15
]. These apparent discrepancies may be a result of subjects in the previous studies being from primary care and the Primary Care Evaluation of Mental Disorders being used for diagnosis.
Furthermore, other previous domestic investigations have reported varying prevalence of depressive disorders and anxiety disorders. Qin et al[46
] reported prevalence of 11.01% for depressive disorders in internal medical outpatients from 23 general hospitals in Shenyang. The prevalence of depression was 12.5% in family practices in Taiwan[25
], while the prevalence of anxiety disorders was 11.61% in six tertiary general hospitals in Shenyang[42
]. Generally speaking, these different results were due to variances in subjects and investigation instruments. The prevalence of depressive disorders and/or anxiety disorders in our study and other domestic studies are lower than results from abroad, which may relate to differences in ethnicity or culture[47,48
The 1.25% current prevalence of dysthymia, the third top depressive disorder in our study, was higher than the 0.6% prevalence in Shanghai subjects reported by the WHO[43
] in 1990, but was similar to the 2.1% mean prevalence for all international sites that participated in the research and the 2.8% prevalence of dysthymia in the study of Qin et al[46
]. It was lower than the 12.6% prevalence of dysthymia among outpatients from 86 general practices in Belgium[45
It is well-known that comorbidity of depressive disorders and anxiety disorders can exacerbate symptoms, and co-occurrence of anxiety is an independent risk factor of suicide among depressive patients[35,49
]. In the current study, anxiety disorders were comorbid in 32.6% of depressive individuals. This comorbid proportion in depressive patients was found to be 68.9% in a study conducted in 15 centers of China[50
], and 50.6% in the United States[51
]. It is a common phenomenon that depressive disorders and anxiety disorders are in comorbidity among outpatients in general medical care.
Detection rate by physicians in general hospitals or primary care
Detection rate in this study was 4.14%, similar to the 4% reported for Shenyang[42,46
]. A United States-based study of outpatients with GI symptoms revealed that 52% of anxious patients and 26% of depressive patients were recognized by gastroenterologists[16
]. Family practices surveyed in Taiwan[25
] indicated that the recognition rate of depression disorders was 12.5%, and that of general anxiety disorder was 8.0%. Prevalence of depression disorders in internal medicine inpatients was 26.9% and only 40% of these patients received antidepressant treatment[52
]. Another MINI-based study of internal medicine inpatients revealed that prevalence of depressive disorders was 26%, and 43.8% of them were treated with antidepressants[53
]. A meta-analysis conducted by Mitchell et al[41
] indicated that correct diagnosis rate of clinicians was 47.3%-50.1%. The remarkable difference in detection rate between other investigations and ours suggests the urgent need to improve the diagnosing rates in mainland China.
Meanwhile, comorbid disorders deserve great attention due to their significant correlation to suicide risk. Current prevalence of depressive disorders with suicidal problems was 3.91% in our study, suggesting that over a quarter of patients with depressive disorders were at suicide risk, while only 4.48% of those patients were recognized. Carson et al[54
] indicated that morbidity of major depression with suicide ideation was 29.9%, while its recognition rate by physicians was 58%. Moreover, prevalence of depression and/or anxiety disorders in our study was higher in females than in males, which is consistent with results in Qin’s study[42,46
], and reminds physicians to pay more attention to female outpatients with mood problems.
Discrepancies of prevalence and detection rate between our study and previous studies likely reflect the limitations of methodology, which require significant effort to be overcome in subsequent research.
These findings confirm the high prevalence of depressive and anxiety disorders and disappointing detection and treatment rate in the GI departments, and highlight the particular challenge posed by the contrasts between these two rates. Although all 13 tertiary hospitals represent the top general hospitals in China, low recognition and treatment rates raise significant concerns and indicate the need to improve the physician’s abilities to diagnose and identify emotional disorders in GI patients.
Several potential explanations exist for the high prevalence of depressive and anxiety disorders and low detection rate in GI outpatients. Physicians are less specialized than psychiatrists in recognizing mental disorders correctly. Furthermore, culture may limit physicians’ abilities in this regard. In the Chinese traditional culture, social and cognitive processes or mental status are closely related, which contributes to interpreting emotional distress and anxiety as social or ethical problems rather than mental disorders. Somatic symptoms can also serve as cultural idioms of depressive emotion[55-57
]. Depressed or anxious people are inclined to experience physical symptoms, masking the underlying mental disorder[39
]. In addition, there is a distorted cognition of mental disorders. It is common to consider depressive individuals as having no self-control and weak. Jorm et al[58
] reported that around a quarter of Australian adults consider antidepressants as harmful to suicidal depressive patients, who are more likely to reject relevant treatments, including psychotherapy. Finally, the established stigma of mental disorders causes hiding of emotional problems and rationalization to resist therapy. Dramatic reports in the mainstream media of aggressive behavior by mental disorder sufferers prejudice both patients and physicians against the disorder[59-61
Previous studies have proven that depressive and anxiety disorders influence prognosis of physical diseases, raise medical risk, and increase economic burden[62,63
]. However, appropriate treatment does benefit recovery from physical disease and maintenance of social function[64-66
]. Therefore, clinicians should improve their ability to diagnose depression and anxiety, especially in patients with complaints of unexplained GI symptoms.
Several limitations exist in the current study. Firstly, excluding outpatients who could not complete the investigation due to severe physical or mental dysfunction may have biased the results since severity of physical symptoms is positively related to depression, anxiety or other mental problems[67,68
]. Secondly, the 385 missing cases (due to busy schedules and denial of mental issues) from the diagnostic interview accounted for 19.3% of the total. There were no statistically significant differences between missing and follow-up cases in sex (χ2
= 0.066, P
= 0.797) or age (t
= -0.860, P
= 0.390). Although statistical adjustment was performed, representation of the sample in the study may have been impacted.
Depressive disorders and anxiety disorders are common in general hospitals and represent significant risks to patients’ quality-of-life. Patients visiting non-psychiatric departments may have at least one somatic symptom which is partly of emotional origin, challenging non-psychiatric physicians to detect emotional disorders.
Emotional disorders in gastrointestinal (GI) patients have been assessed in a number of studies in America, Europe and China, including non-mainland regions of Hong Kong and Taiwan. However, the economic status and cultural traditions of mainland China are quite distinctive from foreign countries and even the non-mainland regions of China. It is important to understand the mental health situation of mainland Chinese GI patients.
Innovations and breakthroughs
The current study determined the prevalence of depressive and/or anxiety disorders and physicians’ detection rates in tertiary care hospitals across mainland China. In particular, this is the first multi-center study from the mainland of China with a large number of patients to report the prevalence of depression and anxiety in adult GI outpatients. Furthermore, the diagnosis of depressive and anxiety disorders was made with the Mini International Neuropsychiatric Interview diagnostic instrument.
The results of this study suggest that clinicians should improve their abilities to detect emotional disorders. Furthermore, they serve to remind the government or medical institutions of the importance of promoting productive interactions between psychiatry and other departments.
This study is well designed including group analysis and statistics. In particular, this is the first multi-center study from the mainland of China with a large number of patients to report the prevalence of depression and anxiety in adult GI outpatients.
Levenstein S, Ackerman S, Kiecolt-Glaser JK, Dubois A. Stress and peptic ulcer disease. JAMA.
Mayer EA. The neurobiology of stress and gastrointestinal disease. Gut.
Bhatia V, Tandon RK. Stress and the gastrointestinal tract. J Gastroenterol Hepatol.
Goodwin RD, Stein MB. Generalized anxiety disorder and peptic ulcer disease among adults in the United States. Psychosom Med.
De la Roca-Chiapas JM, Solís-Ortiz S, Fajardo-Araujo M, Sosa M, Córdova-Fraga T, Rosa-Zarate A. Stress profile, coping style, anxiety, depression, and gastric emptying as predictors of functional dyspepsia: a case-control study. J Psychosom Res.
Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, Drossman DA, Creed F. Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology.
Mussell M, Kroenke K, Spitzer RL, Williams JB, Herzog W, Löwe B. Gastrointestinal symptoms in primary care: prevalence and association with depression and anxiety. J Psychosom Res.
Addolorato G, Mirijello A, D'Angelo C, Leggio L, Ferrulli A, Abenavoli L, Vonghia L, Cardone S, Leso V, Cossari A. State and trait anxiety and depression in patients affected by gastrointestinal diseases: psychometric evaluation of 1641 patients referred to an internal medicine outpatient setting. Int J Clin Pract.
Walker EA, Katon WJ, Jemelka RP, Roy-Bryne PP. Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study. Am J Med.
Löwe B, Spitzer RL, Williams JB, Mussell M, Schellberg D, Kroenke K. Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. Gen Hosp Psychiatry.
Haag S, Senf W, Häuser W, Tagay S, Grandt D, Heuft G, Gerken G, Talley NJ, Holtmann G. Impairment of health-related quality of life in functional dyspepsia and chronic liver disease: the influence of depression and anxiety. Aliment Pharmacol Ther.
Katon W, Lin EH, Kroenke K. The association of depression and anxiety with medical symptom burden in patients with chronic medical illness. Gen Hosp Psychiatry.
Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A. Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis. J Gen Intern Med.
Wittchen HU, Höfler M, Meister W. Prevalence and recognition of depressive syndromes in German primary care settings: poorly recognized and treated?. Int Clin Psychopharmacol.
Kroenke K, Spitzer RL, Williams JB, Monahan PO, Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med.
Keefer L, Sayuk G, Bratten J, Rahimi R, Jones MP. Multicenter study of gastroenterologists' ability to identify anxiety and depression in a new patient encounter and its impact on diagnosis. J Clin Gastroenterol.
Caballero L, Aragonès E, García-Campayo J, Rodríguez-Artalejo F, Ayuso-Mateos JL, Polavieja P, Gómez-Utrero E, Romera I, Gilaberte I. Prevalence, characteristics, and attribution of somatic symptoms in Spanish patients with major depressive disorder seeking primary health care. Psychosomatics.
Kroenke K, Spitzer RL, Williams JB, Linzer M, Hahn SR, deGruy FV, Brody D. Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Arch Fam Med.
Vaccarino AL, Sills TL, Evans KR, Kalali AH. Prevalence and association of somatic symptoms in patients with Major Depressive Disorder. J Affect Disord.
Wang T, Chen YL, Lu YR. A survey of depression patients with physical symptoms as the first symptom attending gastroenterology outpatient clinic of a general hospital: an analysis of 5754 cases. Shijie Huaren Xiaohua Zazhi. 2010;18:851-853.
Simon GE, VonKorff M, Piccinelli M, Fullerton C, Ormel J. An international study of the relation between somatic symptoms and depression. N Engl J Med.
Menchetti M, Belvederi Murri M, Bertakis K, Bortolotti B, Berardi D. Recognition and treatment of depression in primary care: effect of patients' presentation and frequency of consultation. J Psychosom Res.
Mergl R, Seidscheck I, Allgaier AK, Möller HJ, Hegerl U, Henkel V. Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition. Depress Anxiety.
King M, Nazareth I, Levy G, Walker C, Morris R, Weich S, Bellón-Saameño JA, Moreno B, Svab I, Rotar D. Prevalence of common mental disorders in general practice attendees across Europe. Br J Psychiatry.
Liu CY, Chen CY, Cheng AT. Mental illness in a general hospital's family medicine clinic in Taiwan. Psychiatry Clin Neurosci.
Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res.
Ye WF, Xu JM. Application and evaluation of General Hospital Anxiety and Depression Scale in general hospital patients. Zhongguo Xingwei Yixve Zazhi. 1993;2:17-19.
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry.
1998;59 Suppl 20
:22-33; quiz 34-57.[PubMed]
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res.
Lecrubier Y, Sheehan DV, Weiller E, Amorim P, Bonora I, Sheehan KH, Janavs J, Dunbar GC. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiatry.
Sheehan DV, Lecrubier Y, Sheehan KH, Janavs J, Weiller E, Keskiner A, Schinka J, Knapp E, Sheehan MF, Dunbar GC. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur Psychiatry.
Si TM, Shu L, Dang WM, Su YA, Chen JX, Dong WT, Kong QM, Zhang WH. Evaluation of the reliability and validity of chinese version of the Mini-International Neuropsychiatric Interview in patients with mental disorders. Zhongguo Xinli Weisheng Zazhi. 2009;23:493-497.
He YL, Ma H, Zhang L, Liu ZN, Jia FJ, Zhang MY. [A cross-sectional survey of the prevalence of depressive-anxiety disorders among general hospital outpatients in five cities in China]. Zhonghua Neike Zazhi.
Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M, Stein MB. Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry.
Balázs J, Lecrubier Y, Csiszér N, Koszták J, Bitter I. Prevalence and comorbidity of affective disorders in persons making suicide attempts in Hungary: importance of the first depressive episodes and of bipolar II diagnoses. J Affect Disord.
Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry.
Murray CJ, Lopez AD, Jamison DT. The global burden of disease in 1990: summary results, sensitivity analysis and future directions. Bull World Health Organ.
Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry.
Han YC, Zong YH, Zhang YH, Wang WH, Hui XiQ, Wang XQ. Clinical analysis of somatic symptoms in 117 cases with major depression. Zhongguo Xinli Weisheng Zazhi. 2008;22:874-877.
Mitchell AJ, Vaze A, Rao S. Clinical diagnosis of depression in primary care: a meta-analysis. Lancet.
Qin X, Phillips MR, Wang W, Li Y, Jin Q, Ai L, Wei S, Dong G, Liu L. Prevalence and rates of recognition of anxiety disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. Gen Hosp Psychiatry.
Xiao Z, Yan H, Xiao S. Depressive disorders among outpatients in general hospitals. Zhonghua Yixve Zazhi.
Li XY, Zhang YP, Wang ZQ, Yang SJ, Phillips MR. Prevalence of depressive disorders among patients treated in general hospitals in Beijing. Zhongguo Shenjing Jingshen Jibing Zazhi. 2010;36:65-69.
Ansseau M, Dierick M, Buntinkx F, Cnockaert P, De Smedt J, Van Den Haute M, Vander Mijnsbrugge D. High prevalence of mental disorders in primary care. J Affect Disord.
Qin X, Wang W, Jin Q, Ai L, Li Y, Dong G, Liu L, Phillips MR. Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China. J Affect Disord.
Jackson-Triche ME, Greer Sullivan J, Wells KB, Rogers W, Camp P, Mazel R. Depression and health-related quality of life in ethnic minorities seeking care in general medical settings. J Affect Disord.
Riolo SA, Nguyen TA, Greden JF, King CA. Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health.
Moffitt TE, Harrington H, Caspi A, Kim-Cohen J, Goldberg D, Gregory AM, Poulton R. Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. Arch Gen Psychiatry.
Shi SX, Zhang MY, Wu WY, Lu Z, Xin ZT, n ZHi, Liu YL, Zhao JP, Sun XL, Li M. Multi-center study of the clinical features in depression comorbidity with anxiety disorders. Shanghai Jingshen Yixve. 2009;21:198-202.
Fava M, Rankin MA, Wright EC, Alpert JE, Nierenberg AA, Pava J, Rosenbaum JF. Anxiety disorders in major depression. Compr Psychiatry.
Rentsch D, Dumont P, Borgacci S, Carballeira Y, deTonnac N, Archinard M, Andreoli A. Prevalence and treatment of depression in a hospital department of internal medicine. Gen Hosp Psychiatry.
Cigognini MA, Furlanetto LM. Diagnosis and pharmacological treatment of depressive disorders in a general hospital. Rev Bras Psiquiatr.
Carson AJ, Best S, Warlow C, Sharpe M. Suicidal ideation among outpatients at general neurology clinics: prospective study. BMJ.
Kirmayer LJ. Cultural variations in the clinical presentation of depression and anxiety: implications for diagnosis and treatment. J Clin Psychiatry.
2001;62 Suppl 13
:22-28; discussion 29-30.[PubMed]
Kirmayer LJ. Cultural variations in the response to psychiatric disorders and emotional distress. Soc Sci Med.
Lin TY. Psychiatry and Chinese culture. West J Med.
Jorm AF, Christensen H, Griffiths KM. Belief in the harmfulness of antidepressants: results from a national survey of the Australian public. J Affect Disord.
Prior L, Wood F, Lewis G, Pill R. Stigma revisited, disclosure of emotional problems in primary care consultations in Wales. Soc Sci Med.
Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv.
Crisp AH, Gelder MG, Rix S, Meltzer HI, Rowlands OJ. Stigmatisation of people with mental illnesses. Br J Psychiatry.
Weissman MM, Neria Y, Gameroff MJ, Pilowsky DJ, Wickramaratne P, Lantigua R, Shea S, Olfson M. Positive screens for psychiatric disorders in primary care: a long-term follow-up of patients who were not in treatment. Psychiatr Serv.
Tian J, Chen ZC, Hang LF. The effects of psychological status of the patients with digestive system cancers on prognosis of the disease. Cancer Nurs.
Küchler T, Bestmann B, Rappat S, Henne-Bruns D, Wood-Dauphinee S. Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. J Clin Oncol.
Whooley MA, Simon GE. Managing depression in medical outpatients. N Engl J Med.
Wells KB, Sherbourne C, Schoenbaum M, Duan N, Meredith L, Unützer J, Miranda J, Carney MF, Rubenstein LV. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA.
Richardson LP, Lozano P, Russo J, McCauley E, Bush T, Katon W. Asthma symptom burden: relationship to asthma severity and anxiety and depression symptoms. Pediatrics.
Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, Allegra L, Centanni S. Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med.